These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11897051)

  • 41. A robust screen for inhibitors and enhancers of phosphoinositide-3 kinase (PI3K) activities by ratiometric fluorescence superquenching.
    Stankewicz C; Rininsland FH
    J Biomol Screen; 2006 Jun; 11(4):413-22. PubMed ID: 16490774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of peptide substrate and small molecule inhibitors of testis-specific serine/threonine kinase1 (TSSK1) by the developed assays.
    Zhang L; Yan Y; Liu Z; Abliz Z; Liu G
    J Med Chem; 2009 Jul; 52(14):4419-28. PubMed ID: 19530700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A cGMP-dependent protein kinase assay for high throughput screening based on time-resolved fluorescence resonance energy transfer.
    Bader B; Butt E; Palmetshofer A; Walter U; Jarchau T; Drueckes P
    J Biomol Screen; 2001 Aug; 6(4):255-64. PubMed ID: 11689125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-throughput automated confocal microscopy imaging screen of a kinase-focused library to identify p38 mitogen-activated protein kinase inhibitors using the GE InCell 3000 analyzer.
    Trask OJ; Nickischer D; Burton A; Williams RG; Kandasamy RA; Johnston PA; Johnston PA
    Methods Mol Biol; 2009; 565():159-86. PubMed ID: 19551362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform.
    Trask OJ; Baker A; Williams RG; Nickischer D; Kandasamy R; Laethem C; Johnston PA; Johnston PA
    Methods Enzymol; 2006; 414():419-39. PubMed ID: 17110205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A homogeneous, nonradioactive high-throughput fluorogenic protein kinase assay.
    Kupcho K; Somberg R; Bulleit B; Goueli SA
    Anal Biochem; 2003 Jun; 317(2):210-7. PubMed ID: 12758259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists.
    Golla R; Seethala R
    J Biomol Screen; 2002 Dec; 7(6):515-25. PubMed ID: 14599349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Scintillation proximity assay for human DNA topoisomerase I using recombinant biotinyl-fusion protein produced in baculovirus-infected insect cells.
    Lerner CG; Saiki AY
    Anal Biochem; 1996 Sep; 240(2):185-96. PubMed ID: 8811905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacophore modelling and virtual screening for identification of new Aurora-A kinase inhibitors.
    Deng XQ; Wang HY; Zhao YL; Xiang ML; Jiang PD; Cao ZX; Zheng YZ; Luo SD; Yu LT; Wei YQ; Yang SY
    Chem Biol Drug Des; 2008 Jun; 71(6):533-9. PubMed ID: 18410307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a miniaturized assay for the high-throughput screening program for poly(ADP-ribose) polymerase-1.
    Lee S; Koo HN; Lee BH
    Methods Find Exp Clin Pharmacol; 2005 Nov; 27(9):617-22. PubMed ID: 16357945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases.
    Rodems SM; Hamman BD; Lin C; Zhao J; Shah S; Heidary D; Makings L; Stack JH; Pollok BA
    Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):9-19. PubMed ID: 15090152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multi-modality assay platform for ultra-high throughput screening.
    Fowler A; Davies I; Norey C
    Curr Pharm Biotechnol; 2000 Nov; 1(3):265-81. PubMed ID: 11469384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A non-radioactive method for the assay of many serine/threonine-specific protein kinases.
    Ross H; Armstrong CG; Cohen P
    Biochem J; 2002 Sep; 366(Pt 3):977-81. PubMed ID: 12119045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biotinylated peptides for rapid identification of substrates and inhibitors of kinases and phosphatases with fluorescence superquenching.
    Wittenburg S; Stankewicz C; Rininsland F
    Assay Drug Dev Technol; 2006 Oct; 4(5):535-43. PubMed ID: 17115924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [HTRF-based high-throughput PGE2 release prohibition model and application in discovering traditional Chinese medicine active ingredients].
    Bai ZR; Fei HQ; Li N; Cao L; Zhang CF; Wang TJ; Ding G; Wang ZZ; Xiao W
    Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(3):509-513. PubMed ID: 28868872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibody-free peptide substrate screening of serine/threonine kinase (protein kinase A) with a biotinylated detection probe.
    Kim M; Park YS; Shin DS; Kim J; Kim BG; Lee YS
    Anal Biochem; 2011 Jun; 413(1):30-5. PubMed ID: 21310143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Configuration of a scintillation proximity assay for the activity assessment of recombinant human adenine phosphoribosyltransferase.
    Barrett C; Alley J; Pulido JC; Spurling H; Li P; Parsons T; Mallender WD; Bembenek ME
    Assay Drug Dev Technol; 2006 Dec; 4(6):661-9. PubMed ID: 17199504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay.
    Griffiths M; Sundaram H
    Methods Mol Biol; 2011; 731():451-65. PubMed ID: 21516428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using IMAP technology to identify kinase inhibitors: comparison with a substrate depletion approach and analysis of the nature of false positives.
    Singh P; Lillywhite B; Bannaghan C; Broad P
    Comb Chem High Throughput Screen; 2005 Jun; 8(4):319-25. PubMed ID: 16101008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.